Strengthening of Schmelzer's role in ABDA for policy connections
Paul Schmelzer Returns to Pharmaceutical Sector as ABDA's Political Contacts Advisor
Paul Schmelzer, a seasoned professional with a background in pharmaceuticals and health policy, is set to rejoin the pharmaceutical sector as a political contacts advisor at the ABDA - Federal Association of German Pharmacists' Associations e.V.
The ABDA, a well-established association that represents pharmacists at the federal level in Germany, is further strengthening its political staff unit with Schmelzer's appointment. Starting from March 15, 2023, Schmelzer will report directly to Ralf Denda, head of the political staff unit at ABDA.
Schmelzer's work at ABDA will involve managing political contacts, a role that requires his extensive experience in politics. Prior to his new position, he served as the chief of staff for Kristine Luetke, Member of the German Bundestag, from 2024 to 2025. Before that, from 2023 to 2024, Schmelzer was the press spokesperson for Torsten Herbst, another Member of the German Bundestag.
Schmelzer's political career also includes roles in press spokesperson and chief of staff positions. Before diving into politics, he worked as a political advisor for the Association of Private Health Insurers.
Schmelzer's appointment at ABDA marks his return to the pharmaceutical sector after his political roles. His expertise in pharmacy, healthcare policy, and association management is expected to contribute significantly to the shaping of healthcare and pharmacy policies in Germany.
ABDA represents pharmacists at the federal level, focusing on pharmaceutical care, policy, and regulation. Schmelzer’s role at ABDA will involve leadership and advocacy for pharmacists' interests. For the most precise and current details about Schmelzer's exact political role or biography at ABDA, consulting ABDA’s official publications or their website would be advisable.
Schmelzer's return to the pharmaceutical sector as ABDA's Political Contacts Advisor extends beyond a mere professional transition; it also represents his re-entry into the realm of policy-and-legislation, encompassing general-news related to the pharmaceutical industry and healthcare in Germany. As he gears up to manage political contacts with his extensive background in politics, his strategic position within ABDA is poised to significantly impact the shaping of future policy and legislation in the field of pharmacy and healthcare.
